- Risk level
- L1 · Preparation / engagement
- Peak severity
- LOW
- Reviewer
- Dr Amara Naidoo, MBChB (Clinical Lead)
- Owner
- FemiHealth Editorial
- Rule control
- Standard evaluator
- Audit log
- Not required
- Escalation
- Not required
- Marketing suppression
- Not required
- Version
- 1.0.0
- Approved
- 2026-04-01
- Next review
- 2027-04-01
- Evidence source
- South African National Department of Health maternal and women's health guidelines, WHO recommendations, and Tshela Healthcare clinical governance review.
- Review cycle
- Reviewed at least every 12 months, or immediately when national guidance changes.